[HTML] nih.gov

[HTML][HTML] Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - Oncotarget, 2017 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular
communication in the leukemic bone marrow participates in disease development …
被引用次数：55 相关文章
[HTML] oncotarget.com

[HTML][HTML] Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - Oncotarget, 2016 - oncotarget.com
Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in
acute myeloid leukemia (AML) | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home …
[PDF] researchgate.net

[PDF][PDF] Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - researchgate.net
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular
communication in the leukemic bone marrow participates in disease development …

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - Oncotarget, 2017 - hero.epa.gov
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular
communication in the leukemic bone marrow participates in disease development …

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML).

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - Oncotarget, 2017 - europepmc.org
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular
communication in the leukemic bone marrow participates in disease development …

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

M Omsland, Ø Bruserud, BT Gjertsen… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular
communication in the leukemic bone marrow participates in disease development …
[PDF] semanticscholar.org

[PDF][PDF] Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - pdfs.semanticscholar.org
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular
communication in the leukemic bone marrow participates in disease development …

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - Oncotarget, 2016 - oncotarget.com
Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in
acute myeloid leukemia (AML) | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home …

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML).

M Omsland, Ø Bruserud, BT Gjertsen, V Andresen - Oncotarget, 2017 - europepmc.org
Acute myeloid leukemia (AML) is a bone marrow derived blood cancer where intercellular
communication in the leukemic bone marrow participates in disease development …